XML 124 R111.htm IDEA: XBRL DOCUMENT v3.22.4
SEGMENT INFORMATION Segment Assets (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Oct. 31, 2020
Segment Reporting Information [Line Items]      
Segment Reporting Reconciliation Item Assets $ 8,313 $ 7,900  
Cash and cash equivalents 1,053 1,484 $ 1,441
Short-term Investments 0 91  
Prepaid expenses 119 91  
Long-term investments 195 185  
Long term and other receivables 134 126  
Deferred tax assets 259 280  
Right-of-use asset 150 178  
Other 322 341  
Total assets 10,532 10,705  
Capital expenditures 291 188 $ 119
Other Noncurrent Assets [Member]      
Segment Reporting Information [Line Items]      
Deferred tax assets 246 309  
Life Sciences and Applied Markets      
Segment Reporting Information [Line Items]      
Total assets 3,955 3,741  
Capital expenditures 77 64  
Diagnostics and Genomics      
Segment Reporting Information [Line Items]      
Total assets 3,489 3,320  
Capital expenditures 181 100  
Agilent CrossLab      
Segment Reporting Information [Line Items]      
Total assets 869 839  
Capital expenditures 33 24  
Segment Total      
Segment Reporting Information [Line Items]      
Total assets 8,313 7,900  
Capital expenditures $ 291 $ 188